This study found that F. nucleatum, a gram-negative anaerobic bacterium residing in the oral and gastrointestinal tracts, downregulates the expression of the MMR protein MLH1 in CRC via its metabolite butyrate, resulting in dMMR and sensitizing immunotherapy. Here, MLH1 is linked to colorectal carcinoma.